AQR Capital Management
EBS icon

AQR Capital Management’s Emergent Biosolutions EBS Stock Holding History

AQR Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.21M Buy
989,677
+511,648
+107% +$5.3M ﹤0.01% 1442
2025
Q4 		$5.91M Sell
478,029
-108,217
-18% -$1.16M ﹤0.01% 1477
2025
Q3 		$5.17M Buy
+586,246
New +$4.56M ﹤0.01% 1435
2024
Q3 		– Sell
-460,311
Closed -$3.14M – 2788
2024
Q2 		$3.14M Sell
460,311
-591,387
-56% -$2.54M ﹤0.01% 1253
2024
Q1 		$2.6M Buy
1,051,698
+538,282
+105% +$1.21M ﹤0.01% 1282
2023
Q4 		$1.23M Buy
513,416
+334,298
+187% +$786K ﹤0.01% 1528
2023
Q3 		$605K Buy
179,118
+76,007
+74% +$421K ﹤0.01% 1781
2023
Q2 		$758K Sell
103,111
-99,308
-49% -$921K ﹤0.01% 1665
2023
Q1 		$2.04M Sell
202,419
-346,708
-63% -$4.19M ﹤0.01% 1247
2022
Q4 		$6.43M Buy
549,127
+298,253
+119% +$4.62M 0.01% 782
2022
Q3 		$5.27M Buy
250,874
+136,235
+119% +$3.79M 0.01% 823
2022
Q2 		$3.48M Buy
114,639
+28,688
+33% +$979K 0.01% 902
2022
Q1 		$3.53M Sell
85,951
-409,549
-83% -$18.1M 0.01% 941
2021
Q4 		$21.5M Buy
495,500
+132,387
+36% +$5.99M 0.04% 469
2021
Q3 		$18.2M Sell
363,113
-311,166
-46% -$18.8M 0.03% 507
2021
Q2 		$42.5M Buy
674,279
+307,445
+84% +$19.8M 0.07% 296
2021
Q1 		$33.8M Buy
366,834
+184,746
+101% +$18.9M 0.06% 373
2020
Q4 		$16.3M Buy
182,088
+129,074
+243% +$11.8M 0.03% 496
2020
Q3 		$5.48M Sell
53,014
-20,817
-28% -$2.24M 0.01% 751
2020
Q2 		$5.84M Buy
73,831
+1,006
+1% +$75K 0.01% 748
2020
Q1 		$4.21M Sell
72,825
-23,128
-24% -$1.33M 0.01% 837
2019
Q4 		$5.18M Sell
95,953
-33,113
-26% -$1.8M 0.01% 951
2019
Q3 		$6.75M Sell
129,066
-57,026
-31% -$2.66M 0.01% 875
2019
Q2 		$8.99M Sell
186,092
-73,800
-28% -$3.54M 0.01% 798
2019
Q1 		$13.1M Sell
259,892
-19,284
-7% -$1.14M 0.01% 702
2018
Q4 		$16.6M Buy
279,176
+9,430
+3% +$608K 0.02% 592
2018
Q3 		$17.8M Sell
269,746
-7,190
-3% -$420K 0.02% 617
2018
Q2 		$14M Sell
276,936
-62,466
-18% -$3.25M 0.01% 678
2018
Q1 		$17.9M Buy
339,402
+4,918
+1% +$245K 0.02% 617
2017
Q4 		$15.5M Buy
334,484
+68,050
+26% +$2.86M 0.02% 668
2017
Q3 		$10.8M Buy
266,434
+146,945
+123% +$5.32M 0.01% 750
2017
Q2 		$4.05M Sell
119,489
-31,367
-21% -$968K 0.01% 1111
2017
Q1 		$4.38M Sell
150,856
-40,945
-21% -$1.25M 0.01% 1066
2016
Q4 		$6.3M Sell
191,801
-13,444
-7% -$403K 0.01% 940
2016
Q3 		$6.47M Buy
205,245
+90,494
+79% +$2.63M 0.01% 901
2016
Q2 		$3.23M Sell
114,751
-16,388
-12% -$642K 0.01% 1085
2016
Q1 		$4.77M Sell
131,139
-110,015
-46% -$3.89M 0.01% 904
2015
Q4 		$9.65M Buy
241,154
+3,213
+1% +$112K 0.02% 729
2015
Q3 		$6.78M Sell
237,941
-53,427
-18% -$1.76M 0.01% 710
2015
Q2 		$9.6M Buy
291,368
+5,603
+2% +$174K 0.02% 623
2015
Q1 		$8.22M Buy
285,765
+17,302
+6% +$496K 0.02% 603
2014
Q4 		$7.31M Sell
268,463
-8,173
-3% -$195K 0.02% 779
2014
Q3 		$5.89M Sell
276,636
-101,100
-27% -$2.31M 0.02% 763
2014
Q2 		$8.48M Sell
377,736
-77,600
-17% -$1.81M 0.02% 691
2014
Q1 		$11.5M Sell
455,336
-21,000
-4% -$530K 0.03% 538
2013
Q4 		$11M Sell
476,336
-5,300
-1% -$111K 0.03% 568
2013
Q3 		$9.18M Sell
481,636
-40,365
-8% -$721K 0.03% 597
2013
Q2 		$7.53M Buy
+522,001
New +$7.56M 0.03% 683

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management's EBS Position: Q1 2026 in Review

AQR Capital Management increased its Emergent Biosolutions (EBS) stake by 107% in Q1 2026, buying an estimated $5.3M and bringing the position to 989,677 shares worth $8.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

AQR Capital Management first reported a position in EBS in Q2 2013 and has held it in 48 quarters since. The position peaked at $42.5M in Q2 2021. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • AQR Capital Management held 989,677 shares of Emergent Biosolutions worth $8.21M as of Q1 2026.
  • AQR Capital Management bought 511,648 Emergent Biosolutions shares in Q1 2026, an estimated $5.3M.
  • Emergent Biosolutions made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #1442 holding.
  • AQR Capital Management first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 48 quarters since.
  • AQR Capital Management's Emergent Biosolutions position peaked at $42.5M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.